| scholarly article | Q13442814 |
| P2093 | author name string | A Bar-Or | |
| S S Zamvil | |||
| M S Freedman | |||
| J P Antel | |||
| J Nalbantoglu | |||
| M Burnett | |||
| M K Newell | |||
| E McCrea | |||
| A Buddiga | |||
| A Huckstep | |||
| C P Harvey | |||
| E M Villalobos-Menuey | |||
| J H Cabrera | |||
| M B Sorensen | |||
| N Arbour | |||
| R P Tobin | |||
| P2860 | cites work | B cells as under-appreciated mediators of non-auto-immune inflammatory disease | Q37728724 |
| Effects of anti-immunoglobulin antibodies on murine B lymphocytes and humoral immune responses | Q40261368 | ||
| B cell depletion: a novel therapy for autoimmune diabetes? | Q40717754 | ||
| LPS upregulates MHC class II I-A expression in B lymphocytes at transcriptional and at translational levels | Q40911913 | ||
| HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading | Q41064461 | ||
| Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs | Q41154435 | ||
| Lymphocyte programmed cell death is mediated via HLA class II DR. | Q41463716 | ||
| Requirements for the processing of antigen by antigen-presenting B cells. II. Biochemical comparison of the fate of antigen in B cell tumors and macrophages | Q41922305 | ||
| Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection | Q42045023 | ||
| Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. | Q43190647 | ||
| Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection | Q46266432 | ||
| Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. | Q52589485 | ||
| Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling | Q57204114 | ||
| Murine class II (Ia) molecules associate with human invariant chain | Q68749288 | ||
| Out damned CLIP! Out, I say! | Q71798634 | ||
| Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells | Q71930359 | ||
| B cell antigen receptor signaling links biochemical changes in the class II peptide-loading compartment to enhanced processing | Q71943154 | ||
| Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation | Q72756431 | ||
| HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases | Q78008506 | ||
| Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide | Q24630127 | ||
| Pattern recognition receptors and inflammation | Q27861115 | ||
| The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations | Q28142106 | ||
| Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM | Q28613111 | ||
| HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. | Q33299493 | ||
| The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation | Q33815445 | ||
| Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients | Q35585366 | ||
| Activated CD4+CD25+ T cells selectively kill B lymphocytes | Q35848308 | ||
| Visualizing the first 50 hr of the primary immune response to a soluble antigen. | Q35882923 | ||
| Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity | Q36171818 | ||
| Interleukin-induced increase in Ia expression by normal mouse B cells | Q36349192 | ||
| Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes | Q36655503 | ||
| Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution | Q36778450 | ||
| Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. | Q36952605 | ||
| Regulation of MHC II and CD1 antigen presentation: from ubiquity to security. | Q37276471 | ||
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| toll-like receptor | Q408004 | ||
| P304 | page(s) | 779-789 | |
| P577 | publication date | 2010-07-14 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation | |
| P478 | volume | 88 |
| Q104571076 | B. burgdorferisensu lato-induced inhibition of antigen presentation is mediated by RIP1 signaling resulting in impaired functional T cell responses towards Candida albicans |
| Q47565961 | Immune aspects of sepsis and hope for new therapeutics |
| Q24626864 | Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview |
| Q36328761 | The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms |
| Q34374669 | Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration. |
| Q36995893 | Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression on Activated B-Lymphocytes: A Plausible Mechanism for Downregulation of Acute Inflammatory Conditions |
| Q36608155 | γδ T Cells and dendritic cells in refractory Lyme arthritis. |
Search more.